| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 35.068 | 5.421 | 11.128 | 25.000 | 43.644 |
| Total Income - EUR | - | 0 | 1.576 | 1.468 | 1.683 | 43.558 | 97.075 | 195.994 | 59.708 | 48.279 |
| Total Expenses - EUR | - | 167 | 908 | 1.253 | 1.569 | 43.351 | 91.599 | 83.591 | 67.015 | 72.648 |
| Gross Profit/Loss - EUR | - | -167 | 668 | 215 | 114 | 207 | 5.476 | 112.403 | -7.308 | -24.369 |
| Net Profit/Loss - EUR | - | -167 | 648 | 208 | 107 | 204 | 5.421 | 112.292 | -7.826 | -25.678 |
| Employees | - | 0 | 1 | 0 | 0 | 2 | 5 | 6 | 2 | 2 |
Check the financial reports for the company - Oncometrics Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 898 | 2.135 | 3.566 | 11.406 | 40.265 | 157.638 | 111.758 | 71.903 |
| Current Assets | - | 45 | 44 | 43 | 42 | 160.133 | 68.680 | 3.093 | 6.768 | 10.211 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 159.247 | 63.605 | 1.151 | 4.155 | 3.603 |
| Cash | - | 45 | 44 | 43 | 42 | 886 | 5.075 | 1.942 | 2.613 | 6.607 |
| Shareholders Funds | - | -122 | 528 | 726 | 820 | 1.009 | 6.408 | 118.719 | 110.534 | 78.718 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 167 | 414 | 1.452 | 2.788 | 31.970 | 41.693 | 29.634 | 3.595 | 1.765 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 138.561 | 60.844 | 12.377 | 4.397 | 1.630 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncometrics Srl